Author: A4L Admin

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] IDENTIFY Study Results Published in PLOS ONE Washington DC—November 17, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces the publishing of the IDENTIFY Study in PLOS ONE, the multicenter validation...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]Washington DC—October 25, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CorVista System as a first...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row]...